Search Within

Genitourinary Oncology Service

  1. "2004"
Formats
  1. Journal Article (53)
  2. Meeting Abstract (30)
  3. Book Section (1)
Groups
  1. Department of Medicine (84)
  2. Solid Tumor Oncology Division (84)
  3. GSK Faculty (37)
  4. Sloan Kettering Institute Faculty (27)
  5. Molecular Pharmacology and Chemistry Program Faculty (25)
  6. Surgery (22)

More Groups

People
  1. Howard Scher (30)
  2. Robert Motzer (17)
  3. Jason Koutcher (15)
  4. David Solit (13)
  5. Neal Rosen (10)
  6. Victor Reuter (10)

More People

Years
  1. 2004 (84)
Publications
  1. Journal of Clinical Oncology (27)
  2. Cancer Research (8)
  3. Cancer (3)
  4. Journal of Nuclear Medicine (3)
  5. Magnetic Resonance in Medicine (3)
  6. Annals of Oncology (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (27)
  2. American Association for Cancer Research (12)
  3. Elsevier Inc. (7)
  4. Elsevier Science, Inc. (5)
  5. John Wiley & Sons (5)
  6. Springer (5)

More Publishers

Results (84)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Magnetic resonance imaging in mouse cancer models
    Book Section

    Muruganandham, M.; Koutcher, J. A.
    In Holland, E. C. (Eds.) Mouse Models of Human Cancer (2004)

    Fulltext@MSK | Save
  • Restoration of PTEN-expression in tumor cells causes them to depend on EGFR for suppression
    Meeting Abstract

    She, Q.; Moasser, M. M.; Ye, Q.; O'reilly, K.; Solit, D.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • P27 deficiency accelerates progression of prostate cancer initiated by SV40 large T antigen
    Meeting Abstract

    Shaffer, D. R.; Ishiwata, R.; Olgac, S.; Scher, H. I.; Koff, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Development of a yeast based system to study the unique properties of mutant androgen receptors which may play a role in prostate cancer progression
    Meeting Abstract

    Robzyk, K.; Oen, H.; Butler, L.; Tilley, W.; Scher, H.; Rosen, N.; Caplan, A.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Cyclin D expression and G1 progression are dependent on MEK-MAP kinase activity in tumor cells with B-Raf mutation but not in breast cancer cells with wild type Ras and Raf
    Meeting Abstract

    Pratilas, C. A.; Grbovic, O.; Basso, A. D.; Sawai, A.; Chapman, P.; Rosen, N.; Solit, D. B.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Selective killing of drug-resistant mammary carcinoma by exploiting the tumor cell ATP viability threshold
    Meeting Abstract

    Martin, D. S.; Alfieri, A. A.; Koutcher, J. A.; Spriggs, D. R.; Norton, L.; Bertino, J. R.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Activated, mutated B-raf protein kinase requires the HSP90 chaperone for folding and stability and is degraded in response to HSP90 inhibitors
    Meeting Abstract

    Grbovic, O. M.; Basso, A. D.; Friedlander, P.; Houghton, A.; Solit, D. B.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • Combinatorial targeting of oncogenesis via a novel rationally designed Hsp90 inhibitor
    Meeting Abstract

    Chiosis, G.; Solit, D.; Vilenchik, M.; Rosen, N.
    Cancer Research (2004)

    Fulltext@MSK | Save
  • 17-allylamino-17-demethoxygeldanamycin (17-AAG) abrogates the G(2)/M cell cycle checkpoint by down-regulating chk1 and selectively sensitizes tumor cells with defective p53 to topoisomerase I poison
    Meeting Abstract

    Tse, A. N.; Solit, D.; Rosen, N.; Schwartz, G.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Primary retroperitoneal lymph node dissection (RPLND) for non-seminomatous germ-cell tumor (NSGCT): Impact of trends in patient selection on retroperitoneal pathology and outcome
    Meeting Abstract

    Stephenson, A. J.; Bosl, G. J.; Motzer, R. J.; Bajorin, D. F.; Stasi, J. P.; Sheinfeld, J.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save